• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

2-(Piperidin-3-yl)propan-2-ol hydrochloride

2-(Piperidin-3-yl)propan-2-ol hydrochloride, also known by its CAS number 1003560-59-5, is a compound of significant interest in the fields of organic chemistry and pharmaceutical research. This compound is a hydrochloride salt of 2-(piperidin-3-yl)propan-2-ol, which is a tertiary alcohol derivative of piperidine, a six-membered saturated heterocyclic amine. The structure of this compound is characterized by a piperidine ring substituted at the third position with a propanol group, resulting in a unique stereochemistry and reactivity.

The synthesis of 1003560-59-5 typically involves multi-step organic reactions, including nucleophilic substitution, reduction, and acid-base neutralization. The compound has been studied for its potential applications in drug design, particularly as a precursor or intermediate in the synthesis of bioactive molecules. Recent research has highlighted its role in the development of novel therapeutic agents targeting various biological pathways, including those involved in inflammation, pain management, and neurodegenerative diseases.

One of the key features of 2-(Piperidin-3-yl)propan-2-ol hydrochloride is its ability to act as a chiral auxiliary or catalyst in asymmetric synthesis. This property has made it valuable in the construction of complex molecular architectures with high enantioselectivity. Additionally, the compound exhibits interesting pharmacokinetic properties, making it a promising candidate for drug delivery systems.

Recent studies have also explored the interaction of 1003560-59-5 with biological macromolecules such as proteins and nucleic acids. These investigations have provided insights into its potential as a modulator of enzyme activity or as a component in gene therapy vectors. Furthermore, the compound has been evaluated for its antioxidant and anti-inflammatory properties, which could be harnessed in the development of nutraceuticals and cosmeceuticals.

In terms of industrial applications, 2-(Piperidin-3-yl)propan-2-ol hydrochloride has found utility in the formulation of specialty chemicals and advanced materials. Its ability to participate in various chemical transformations under mild conditions makes it an attractive building block for material scientists and process engineers.

The growing interest in 1003560-59-5 can be attributed to its versatile chemical properties and the increasing demand for innovative solutions in healthcare and materials science. As research continues to uncover new aspects of this compound's behavior and functionality, it is expected to play an even more prominent role in both academic and industrial settings.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)